Volitionrx (VNRX) EBIT Margin (2019 - 2025)
Volitionrx's EBIT Margin history spans 9 years, with the latest figure at 1329.65% for Q4 2025.
- For Q4 2025, EBIT Margin rose 168685.0% year-over-year to 1329.65%; the TTM value through Dec 2025 reached 1399.05%, up 101946.0%, while the annual FY2025 figure was 1702.88%, 48802.0% up from the prior year.
- EBIT Margin reached 1329.65% in Q4 2025 per VNRX's latest filing, down from 947.47% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 947.47% in Q3 2025 to a low of 61692.56% in Q4 2021.
- Average EBIT Margin over 5 years is 11710.72%, with a median of 5062.75% recorded in 2024.
- Peak YoY movement for EBIT Margin: soared 190771026bps in 2021, then skyrocketed 28929bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 61692.56% in 2021, then skyrocketed by 89bps to 6691.45% in 2022, then skyrocketed by 46bps to 3582.6% in 2023, then grew by 16bps to 3016.5% in 2024, then skyrocketed by 56bps to 1329.65% in 2025.
- Per Business Quant, the three most recent readings for VNRX's EBIT Margin are 1329.65% (Q4 2025), 947.47% (Q3 2025), and 1548.56% (Q2 2025).